After decades battling a deadly crop disease, Brazilian orange farmers finally hit on a way to expand supply by moving some production to the country’s northeast.

AMERICAN patients will pay the cost of Donald Trump’s 15 per cent tariffs on Europe’s pharmaceutical industry, an Irish pharma company boss has warned. The US Government today clarified that

The 15% tariff would be lower than previously threatened, but it would remain a high duty on America’s largest trading partner.

Trump is targeting China's transshipments through Southeast Asia. But can tariffs and trade agreements really curb China's regional exports?

The European pharmaceutical industry said Tuesday that it remained concerned a EU-US trade deal reached at the weekend does not provide certainty for critical sector. The EFPIA trade association for the European pharmaceutical industry said it was monitoring announcements on the details of the deal "as key implications for the pharmaceutical sector remain uncertain".

The announcement and anticipation of US tariffs have already had an immediate and devastating impact on trade performance.

The construction market in the United States is expected to be the most impacted by tariff policies and will slow throughout the latter half of 2025 and into 2026.

Cipla's CEO addresses impact of US tariffs on pharmaceutical industry, remains optimistic about company's performance and future growth.